Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative 131I whole-body scan results: A meta-analysis

dc.contributor.authorCaetano, Rosângela
dc.contributor.authorBastos, Claudia Regina Garcia
dc.contributor.authorOliveira, Ione Ayala Gualandi de
dc.contributor.authorSilva, Rondineli Mendes da
dc.contributor.authorFortes, Clarisse Pereira Dias Drumond
dc.contributor.authorPepe, Vera Lucia Edais
dc.contributor.authorReis, Lenice Gnocchi
dc.contributor.authorBraga, Jose Ueleres
dc.date.accessioned2024-11-21T17:49:55Z
dc.date.available2024-11-21T17:49:55Z
dc.date.issued2016
dc.description.abstractBackground. The purpose of this review was to present a meta-analysis aimed to evaluate the accuracy of positron emission tomography (PET) and PET-CT for detecting recurrence of differentiated thyroid carcinoma (DTC) not identified by 131I whole-body scintigraphy. Methods. MEDLINE, EMBASE, LILACS, and Cochrane databases were searched for studies published between January 1985 and March 2012. Systematic methods were used to select and evaluate the quality of studies. Pooled sensitivity and specificity for conventional PET and PET- CT was estimated using random effects model. Results. Twenty studies were included in the systematic review; the data of 18 studies were used in the meta-analysis. The combined sensitivity and specificity for conventional PET were both found to be 84%; for PET- CT, they were 93% and 81%, respectively. The overall accuracies were 91% and 93%, respectively. Conclusion. 18Fluorodeoxyglucose (FDG)-PET and PET-CT are highly accurate diagnostics tools for DTC recurrence in patients who present a negative whole-body scintigraphy and could impact the clinical and ther- apeutic management of DTC. VC 2015 Wiley Periodicals, Inc. Head Neck 38: 316–327, 2016.
dc.identifier.citationCaetano R, Bastos CR, de Oliveira IA, da Silva RM, Fortes CP, Pepe VL, Reis LG, Braga JU. Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis. Head Neck. 2016 Feb;38(2):316-27. doi: 10.1002/hed.23881.
dc.identifier.otherDOI: 10.1002/hed.23881
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/614
dc.language.isoen
dc.publisherHead & Neck
dc.subjectthyroid canceren
dc.subjectdifferentiated thyroid carcinomaen
dc.subjectnegative radioiodine whole-body scanen
dc.subject18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET),en
dc.subjectmeta-analysisen
dc.titleAccuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative 131I whole-body scan results: A meta-analysis
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Caetano R et al_Clin Rev.pdf
Tamanho:
12.9 KB
Formato:
Adobe Portable Document Format
Descrição:
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição: